Abdulkader Rahmo

Company: SMS Biotech

Job title: President and CSO

Seminars:

Minimizing Risk in Regenerative Therapies 3:15 pm

Delivering partial reprogramming to reduce the risk of tumorigenicity Preventing off-target effects and ensuring expression is only seen in the organ of interest Tackling dosage and delivery challenges in regenerative therapiesRead more

day: Conference Day One